Skip to main content
Clinical Trials/RBR-46gs8pk
RBR-46gs8pk
Not yet recruiting
Phase 4

Interaction and effect of the COVID-19 pandemic on tuberculosis control in the state of São Paulo: political-social, clinical-epidemiological aspects and innovative practices

Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo0 sitesAugust 15, 2024

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Tuberculosis, Pulmonary
Sponsor
Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 15, 2024
End Date
March 1, 2028
Last Updated
last year
Study Type
Intervention

Investigators

Sponsor
Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo

Eligibility Criteria

Inclusion Criteria

  • Managers from different levels (federal, state, regional, and municipal) will be included. Health and social assistance professionals who have worked in healthcare and/or health surveillance for at least six months, starting from September 2019, due to their prior experience before the pandemic context. Representatives of social movements and health councils (national, state, municipal, and local) who have at least six months of experience will also be interviewed. All cases and deaths from tuberculosis (TB) reported in the Notifiable Diseases Information System (SINAN) from 2015 to 2022 and cases and deaths from COVID\-19 from 2020 to 2022 available on the Coronavirus Panel will be considered. The population for this study phase will consist of people undergoing treatment for TB. No gender criteria apply. Professionals who are part of the health team responsible for Directly Observed Treatment (DOT). Managers of the units (Primary Health Care (PHC) coordinators and/or coordinators of PHC units in the municipalities and units previously selected)

Exclusion Criteria

  • Serão excluídos gestores ou profissionais que não respondam a três contatos seguidos. Só serão considerados os casos e óbitos notificados como causa básica tuberculose ou COVID\-19 dentro do período citado; outras doenças ou notificações fora do período serão excluídas. Serão excluídas pessoas que não estejam fazendo tratamento para tuberculose (TB) no momento e profissionais de saúde que não atuem no Tratamento Diretamente Observado (TDO), exceto gestores das unidades

Outcomes

Primary Outcomes

Not specified

Similar Trials